CLINICAL_TRIALS
withdrawal
· 2012-02-20
Clinical Trial Update: SCH-900105 in Recurrent Glioblastoma [Phase 1]
Summary
A Phase 1 trial of SCH-900105 for recurrent glioblastoma has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Glioblastoma | Phase 1 | Status: WITHDRAWN